Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85


Same quality - higher price? The paradox of allocation: the first national single center analysis after the implementation of the new Swiss transplantation law: the ICU view.

Oberkofler CE, Stocker R, Raptis DA, Stover JF, Schuepbach RA, Müllhaupt B, Dutkowski P, Clavien PA, Béchir M.

Clin Transplant. 2011 Nov-Dec;25(6):921-8. doi: 10.1111/j.1399-0012.2010.01364.x. Epub 2010 Nov 26.


The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.

Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA.

Liver Transpl. 2011 Jun;17(6):674-84. doi: 10.1002/lt.22228.


Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.

Oberkofler CE, Dutkowski P, Stocker R, Schuepbach RA, Stover JF, Clavien PA, Béchir M.

Crit Care. 2010;14(3):R117. doi: 10.1186/cc9068. Epub 2010 Jun 15.


LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience.

Bruns H, Hillebrand N, Schneider T, Hinz U, Fischer L, Schmidt J, Goldschmidt AJ, Schemmer P.

Clin Transplant. 2011 Sep-Oct;25(5):E558-65. doi: 10.1111/j.1399-0012.2011.01483.x. Epub 2011 May 17.


Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.

Li H, Li B, Wei Y, Yan L, Wen T, Xu M, Wang W, Yang J.

PLoS One. 2013 Sep 11;8(9):e74081. doi: 10.1371/journal.pone.0074081. eCollection 2013.


The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.

Freitas AC, Itikawa WM, Kurogi AS, Stadnik LG, Parolin MB, Coelho JC.

Arq Gastroenterol. 2010 Jul-Sep;47(3):233-7.


Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.

Foxton MR, Al-Freah MA, Portal AJ, Sizer E, Bernal W, Auzinger G, Rela M, Wendon JA, Heaton ND, O'Grady JG, Heneghan MA.

Liver Transpl. 2010 May;16(5):668-77. doi: 10.1002/lt.22027.


Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.

Weismüller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, Beckebaum S, Paul A, Scherer MN, Schmidt HH, Schlitt HJ, Neuhaus P, Klempnauer J, Pratschke J, Manns MP, Strassburg CP.

Transpl Int. 2011 Jan;24(1):91-9. doi: 10.1111/j.1432-2277.2010.01161.x. Epub 2010 Sep 3.


Impact of Model for End-Stage Liver Disease in the occurrence of infectious events and survival in a cohort of liver transplant recipients.

Clemente WT, Romanelli RM, Faria LC, Lima SS, Jesus LA, Cortes JR, Sanches MD, Cançado OL, Lima AS.

Transplant Proc. 2013 Jan-Feb;45(1):297-300. doi: 10.1016/j.transproceed.2012.02.046.


Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation.

Machicao VI, Srinivas TR, Hemming AW, Soldevila-Pico C, Firpi RJ, Reed AI, Morelli GJ, Nelson DR, Abdelmalek MF.

Liver Transpl. 2006 May;12(5):754-61.


The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.

Schaffer RL 3rd, Kulkarni S, Harper A, Millis JM, Cronin DC 2nd.

Liver Transpl. 2003 Nov;9(11):1211-5.


Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: a single-center experience.

Umgelter A, Lange K, Kornberg A, Büchler P, Friess H, Schmid RM.

Transplant Proc. 2011 Dec;43(10):3762-8. doi: 10.1016/j.transproceed.2011.08.110.


Marginal grafts increase early mortality in liver transplantation.

Bacchella T, Galvão FH, Jesus de Almeida JL, Figueira ER, de Moraes A, César Machado MC.

Sao Paulo Med J. 2008 May 1;126(3):161-5.


The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.

Weismüller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP.

Transpl Int. 2009 Oct;22(10):970-8. doi: 10.1111/j.1432-2277.2009.00915.x. Epub 2009 Jul 10.


Impact of the MELD allocation after its implementation in liver transplantation.

Benckert C, Quante M, Thelen A, Bartels M, Laudi S, Berg T, Kaisers U, Jonas S.

Scand J Gastroenterol. 2011 Jul;46(7-8):941-8. doi: 10.3109/00365521.2011.568521. Epub 2011 Mar 28.


Live donor liver transplantation in high MELD score recipients.

Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Levy GA, Renner EL, Grant DR.

Ann Surg. 2010 Jan;251(1):153-7. doi: 10.1097/SLA.0b013e3181bc9c6a.


The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients.

Klinzing S, Brandi G, Stehberger PA, Raptis DA, Béchir M.

BMC Anesthesiol. 2014 Nov 15;14:103. doi: 10.1186/1471-2253-14-103. eCollection 2014.


Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission.

Buchanan P, Dzebisashvili N, Lentine KL, Axelrod DA, Schnitzler MA, Salvalaggio PR.

Liver Transpl. 2009 Oct;15(10):1270-7. doi: 10.1002/lt.21802.


Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.

Liver Transpl. 2003 Jul;9(7):737-40.


Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unit.

Aggarwal A, Ong JP, Goormastic M, Nelson DR, Arroliga AC, Farquhar L, Mayes J, Younossi ZM.

Transplant Proc. 2003 Dec;35(8):2998-3002.


Supplemental Content

Support Center